Adverse events following immunisation with four-component meningococcal serogroup B vaccine (4CMenB): Interaction with co-Administration of routine infant vaccines and risk of recurrence in European randomised controlled trials

Joseline Guetsop Zafack, Alexandre Bureau, Danuta M. Skowronski, Gaston De Serres

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Adverse events following immunisation with four-component meningococcal serogroup B vaccine (4CMenB): Interaction with co-Administration of routine infant vaccines and risk of recurrence in European randomised controlled trials'. Together they form a unique fingerprint.

Medicine & Life Sciences